Verbatim response from Perplexity
Without insurance, GLP-1 medications typically cost $900 to $1,400 per month at traditional retail pharmacies, depending on the specific drug and dose [1][2].
However, costs can be significantly lower if you use manufacturer self-pay programs or purchase oral formulations, which currently range from approximately $149 to $449 per month for many patients [1][3][6].
Specific brand costs for self-pay patients include:
| Medication (Brand) | Form | Approx. Self-Pay Cost (Monthly) |
|---|---|---|
| Wegovy (semaglutide) | Oral pill (1.5–4 mg) | $149 – $199 [1][3][7] |
| Wegovy (semaglutide) | Injectable (maintenance) | $349 [6][7] |
| Zepbound (tirzepatide) | Injectable (KwikPen) | $299 – $449 [1][3][6] |
| Ozempic (semaglutide) | Injectable (introductory) | $199 (first 2 fills) [5][7] |
| Ozempic (semaglutide) | Injectable (ongoing) | $349 [6] |
| Foundayo (orforglipron) | Oral pill | $149 – $299 [1][5][7] |
Recommendations for lower costs:
- Choose Oral Options: If eligible, the oral versions of Wegovy and Foundayo are the most affordable cash-pay options, starting at $149/month [1][3].
- Use Manufacturer Savings Cards: Programs from Novo Nordisk (Wegovy) and Eli Lilly (Zepbound/Foundayo) offer these reduced self-pay rates directly [3][6][7].
- Avoid Compounded Versions: While compounded semaglutide can cost as low as $100–$300/month, it is not FDA-approved and varies by platform [1][4].
For the most reliable pricing without insurance, check the official self-pay pages for Novo Nordisk and Eli Lilly, as these are the primary sources for the $149–$449 price range [3][6].